Table 3.
Factors influencing thyroid gland function during pregnancy.
Response variable | Gestational period | Predictor variable | B (slope) | Std. error | t | Stand. coefficient (β) | 95% CI for B | P-value | VIF (1) | DW (2) | R 2 (%) (3) | ANOVA (4) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
TSH | wk. 6–9 | Intercept | 3.792 | 0.501 | 7.566 | 2.806 | =4.779 | 1.575 | 10.6 | F(3, 278) = 11.0 P < 0.001 | ||
Anti-TPO | 0.003 | 0.001 | 4.005 | 0.228 | 0.002–0.005 | <0.001 | 1.08 | |||||
βHCG | 0.000 | 0.000 | −3.735 | −0.212 | 0.000–0.000 | <0.001 | 1.24 | |||||
Estradiol | 7.462E−5 | 0.000 | 2.259 | 0.129 | 0.000–0.000 | =0.025 | 2.59 | |||||
mo. 6–9 | Intercept | 0.987 | 0.535 | 1.843 | −0.068 to 2.042 | =0.067 | 1.612 | 2.4 | F(1, 225) = 5.4 P = 0.021 | |||
Progesterone | 0.007 | 0.003 | 2.331 | 0.154 | 0.001–0.013 | =0.021 | ||||||
fT4 | wk. 6–9 | Intercept | 18.024 | 0.358 | 50.277 | 17.318–18.730 | <0.001 | 1.599 | 1.8 | F(1, 280) = 5.1 P = 0.024 | ||
Progesterone | −0.006 | 0.003 | −2.268 | −0.134 | −0.011 to −0.001 | =0.024 | ||||||
mo. 6–9 | Intercept | 16.876 | 0.976 | 17.473 | 14.953–18.800 | <0.001 | 1.686 | 13.6 | F(2, 225) = 17.7 P < 0.001 | |||
Progesterone | −0.023 | 0.005 | −4.322 | −0.269 | −0.033 to 0.012 | <0.001 | 1.00 | |||||
Anti-TPO | 0.010 | 0.002 | 3.953 | 0.246 | 0.005–0.015 | <0.001 | 1.00 | |||||
fT3 | wk. 6–9 | Intercept | 4.895 | 0.045 | 109.179 | 4.807–4.983 | <0.001 | 1.745 | 2.6 | F(1, 280) = 7.5 P = 0.007 | ||
Anti-TPO | −0.001 | 0.000 | −2.738 | −0.162 | −0.001 to 0.000 | =0.007 | ||||||
mo. 6–9 | Intercept | 4.443 | 0.209 | 21.231 | 4.031–4.856 | <0.001 | 2.000 | 2.3 | F(1, 225) = 5.3 P = 0.023 | |||
Progesterone | −0.003 | 0.001 | −2.291 | −0.151 | −0.005 to 0.000 | =0.023 | ||||||
Prolactin | wk. 6–9 | Intercept | 586.698 | 144.331 | 4.065 | 302.578–870.819 | <0.001 | 1.808 | 26.0 | F(3, 278) = 32.6 P < 0.001 | ||
Estradiol | 0.089 | 0.026 | 3.440 | 0.287 | 0.038–0.140 | <0.001 | 2.88 | |||||
Progesterone | 4.092 | 1.518 | 2.697 | 0.226 | 1.105–7.080 | =0.007 | 2.88 | |||||
Anti-TPO | −0.885 | 0.386 | −2.291 | −0.119 | −1.646 to −0.125 | =0.023 | 1.00 | |||||
mo. 6–9 | Intercept | 2777.394 | 899.877 | 3.086 | 1004.086–4550.702 | =0.002 | 2.076 | 10.7 | F(2, 224) = 13.4 P < 0.001 | |||
Progesterone | 23.506 | 5.082 | 4.625 | 0.305 | 13.491–33.520 | <0.001 | 1.88 | |||||
Estradiol | −0.123 | 0.035 | −3.532 | −0.233 | −0.192 to −0.054 | <0.001 | 1.88 |
(1) VIF denominates the variance inflation factor (VIF = 1/(1 − R2)), which is a marker of collinearity. A value of 1 indicates no collinearity. Values up to 5 indicate moderate collinearity.
(2) DW denominates the result of the Durbin–Watson test, which should optimally be between 1.5 and 2.5.
(3) R2 denominates the coefficient of multiple determination.
(4) ANOVA findings are reported in APA format: F (regression degrees of freedom, residual degree of freedom) = F-ratio.
TSH, thyroid-stimulating hormone; fT4, free thyroxine; fT3, free triiodothyronine.